The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final overall survival (OS) from PROSPER: A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC).
 
Cora N. Sternberg
No Relationships to Disclose
 
Karim Fizazi
No Relationships to Disclose
 
Fred Saad
No Relationships to Disclose
 
Neal D. Shore
No Relationships to Disclose
 
Ugo De Giorgi
No Relationships to Disclose
 
David F. Penson
No Relationships to Disclose
 
Ubirajara Ferreira
No Relationships to Disclose
 
Petro Ivashchenko
No Relationships to Disclose
 
Eleni Efstathiou
No Relationships to Disclose
 
Katarzyna Madziarska
No Relationships to Disclose
 
Michael Paul Kolinsky
No Relationships to Disclose
 
Daniel Iracema Cubero
No Relationships to Disclose
 
Bettina Noerby
No Relationships to Disclose
 
Fabian Zohren
No Relationships to Disclose
 
Xun Lin
No Relationships to Disclose
 
Katharina Modelska
No Relationships to Disclose
 
Jennifer Sugg
No Relationships to Disclose
 
Joyce Leta Steinberg
No Relationships to Disclose
 
Maha H. A. Hussain
No Relationships to Disclose